SCHEMBL3637205

SCHEMBL3637205

N#Cc1ccc(Oc2c(Cl)ccc(CBr)c2F)c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.39
SLC6A4 P31645 4/20 0.39
HTR2A P28223 2/20 0.39
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
SLC6A3 Q01959 1/20 0.38
AR P10275 1/20 0.36
CYP11B1 P15538 1/20 0.35
USP30 Q70CQ3 1/20 0.34
NR3C1 P04150 2/20 0.34
PGR P06401 2/20 0.34
NR3C2 P08235 2/20 0.34
ICMT O60725 1/20 0.33
SLC22A12 Q96S37 1/20 0.32
MRGPRX4 Q96LA9 2/20 0.32
SLC6A2 P23975 1/20 0.32
VCAM1 P19320 1/20 0.31
GPR6 P46095 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3639500 0.88 KCNH2 (0.39) KCNH2SLC6A4HTR2ACYP3A4CYP2C9
Bromide SCHEMBL3636700 0.86 KCNH2 (0.39) KCNH2SLC6A4HTR2ACYP3A4CYP2C9
SCHEMBL3633549 0.81 AR (0.47) KCNH2SLC6A4HTR2ACYP3A4CYP2C9
SCHEMBL3635141 0.78 CYP3A4 (0.58) CYP3A4CYP2C9CYP2C19
SCHEMBL3022832 0.78 CYP3A4 (0.56) KCNH2SLC6A4HTR2ACYP3A4CYP2C9
SCHEMBL3638581 0.77 CYP3A4 (0.50) KCNH2SLC6A4HTR2ACYP3A4CYP2C9
SCHEMBL3022319 0.77 CYP3A4 (0.36) KCNH2SLC6A4HTR2ACYP3A4CYP2C9
SCHEMBL3034711 0.77 CYP3A4 (0.48) KCNH2SLC6A4HTR2ACYP3A4CYP2C9
SCHEMBL3022299 0.76 GRM5 (0.42) KCNH2HTR2ACYP3A4CYP2C9CYP2C19
SCHEMBL3033155 0.74 CYP3A4 (0.39) KCNH2SLC6A4HTR2ACYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 US disclosed
EP-2166856-A1 CHEMICAL COMPOUNDS GlaxoSmithKline LLC (US) 2010-03-31 EP disclosed
WO-2008154271-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2008-12-18 WO disclosed